ARTICLE | Finance
Qiming’s cross-border connection
How Qiming’s first U.S. fund could foster cross-border biotech collaborations
April 21, 2018 12:16 AM UTC
Qiming Venture Partners chose to focus its first ex-China fund on healthcare because the firm sees more interest in cross-border collaborations in life sciences than some of the other industries it invests in.
Qiming unveiled the $120 million fund on April 16, when it also announced it raised nearly $1.3 billion across two China funds that will invest in healthcare, IT, cleantech, internet and consumer companies...